DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Gluz O, Nitz U, Liedtke C. et al.
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs
Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized
WSG-ADAPT-TN Trial Results.
J Natl Cancer Inst 2018;
110: 628-637
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.